Vanadium Compounds as Biocatalyst Models

Vanadium Compounds as PTP Inhibitors.

Phosphotyrosine signaling is regulated by the opposing actions of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs). Here we discuss the potential of vanadium derivatives as PTP enzyme inhibitors and metallotherapeutics. We describe how vanadate in the V oxidized state is thought to inhibit PTPs, thus acting as a pan-inhibitor of this enzyme superfamily. We discuss recent...

Vanadium Pentoxide and Other Inorganic Vanadium Compounds

Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases

This paper discusses how the activity and expression of cyclooxygenases are influenced by vanadium compounds at anticancer concentrations and recorded in inorganic vanadium poisonings. We refer mainly to the effects of vanadate (orthovanadate), vanadyl and pervanadate ions; the main focus is placed on their impact on intracellular signaling. We describe the exact mechanism of the effect of vana...

Vanadium compounds biological actions and potential as pharmacological agents.

Vanadium is an element found in low concentrations in mammals, for which a function remains to be discovered. Over the past century, vanadium compounds have been suggested anecdotally as therapeutic agents for a variety of diseases. The discovery that vanadate inhibits various enzymes, in particular protein tyrosine phosphatases, and mimics many of the biological actions of insulin suggested a ...

Immobilized Vanadium Compounds within Nanoreactors of Al-MCM-41 as Catalyst for Epoxidation of Alkenes

VO2+ and its complexes with ethylenediamine (en), acetylacetonate (acac), 2, 2’-bipyridine(bpy) ligands, immobilized within nanoreactors of Al-MCM-41 designated as VO2+/Al-MCM-41 or VOL2/Al-MCM-41, were prepared and characterized by X-ray powder diffraction (XRD), FT-IR, BET nitrogen adsorption-desorption and chemical analysis techniques. VO2+/Al-MCM-41 and VOL2/Al-MCM-41 were found to catalyze...